IMMUNOSEQ DX Trademark

Trademark Overview


On Wednesday, March 27, 2019, a trademark application was filed for IMMUNOSEQ DX with the United States Patent and Trademark Office. The USPTO has given the IMMUNOSEQ DX trademark a serial number of 88359598. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 27, 2021. This trademark is owned by Adaptive Biotechnologies Corporation. The IMMUNOSEQ DX trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune disease and infection

Providing medical diagnostic and prognostic testing for cancer, autoimmune disease and infection, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; medical services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Medical laboratory services
immunoseq dx

General Information


Serial Number88359598
Word MarkIMMUNOSEQ DX
Filing DateWednesday, March 27, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements


Goods and ServicesMedical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune disease and infection
Pseudo MarkIMMUNOSE EQ DX
Goods and ServicesProviding medical diagnostic and prognostic testing for cancer, autoimmune disease and infection, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; medical services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Disclaimer with Predetermined Text"DX"
Goods and ServicesMedical laboratory services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 15, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 18, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptive Biotechnologies Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Party NameAdaptive Biotechnologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Monday, September 27, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 27, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2021SOU EXTENSION 2 GRANTED
Thursday, February 25, 2021SOU EXTENSION 2 FILED
Thursday, February 25, 2021TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 21, 2020SOU EXTENSION 1 GRANTED
Friday, August 21, 2020SOU EXTENSION 1 FILED
Friday, August 21, 2020TEAS EXTENSION RECEIVED
Tuesday, February 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 22, 2019ASSIGNED TO LIE
Tuesday, November 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 4, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, June 4, 2019PRIORITY ACTION E-MAILED
Tuesday, June 4, 2019PRIORITY ACTION WRITTEN
Tuesday, May 28, 2019ASSIGNED TO EXAMINER
Monday, April 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 30, 2019NEW APPLICATION ENTERED IN TRAM